ATCC 2023 Holiday Shipping Schedule: We will be closed from December 22nd to January 1st. To ensure timely delivery, please submit orders in accordance with the following: Domestic orders no later than December 15th for shipment by December 20th 2023; International orders no later than December 12th for shipment by the first week of January 2024. We will resume our normal shipping schedule on January 2nd, 2024. Thank you for your cooperation. 

  • Quick Order
  • Careers
  • Support

NCI Selects ATCC to Provide End-to-End Cancer Epidemiology Services

News Release

Five-year contract includes customized support for collection, tracking, storage and distribution of human biospecimens and environmental samples.

Manassas, VA, United States

March 14, 2017

The National Cancer Institute (NCI) recently awarded ATCC, a global leader in biological materials development, management and standards, a five-year indefinite-delivery/indefinite-quantity (IDIQ) contract to support the Division of Cancer Epidemiology and Genetics’ (DCEG) Molecular Epidemiology Assay Support (MEAS) program.

DCEG’s mission is to conduct population and multidisciplinary research to discover the genetic and environmental determinants of cancer and new approaches to cancer prevention. The MEAS program provides support services for studies on the genetic and other cellular events that influence the onset of different types of cancer.

Under the contract, ATCC will provide collection supplies to study sites; perform aliquoting and advanced molecular assays; and provide short-term storage for human biospecimens and environmental samples obtained through family and population-based collection efforts, both domestically and internationally. ATCC will track all specimens using a customized biospecimen inventory and resource management system, ensuring that specimens are safeguarded appropriately for use in long-term epidemiology research projects.

“We understand that the proper collection, tracking and storage of specimens is of critical importance to cancer research, and take pride in maintaining and distributing these unique samples to the global research community,” said Dr. Joseph Leonelli, vice president for ATCC’s Microbiology and Government Solutions business. “We are excited to expand our relationship with The National Cancer Institute through this program, and look forward to expanding our clinical study capabilities to support advancements in cancer research.”

About ATCC

ATCC is a premier global biological materials and information resource and standards organization and the leading developer and supplier of authenticated cell lines, microorganisms, and associated data for academia, industry, and government. With a history of scientific contributions spanning nearly a century, ATCC offers an unmatched combination of being the world’s largest and most diverse collection of biological reference materials and data, and is a mission-driven, trusted partner that supports and encourages scientific collaboration. ATCC products, services, partnerships, and people provide the global scientific community with credible, advanced, model systems to support complex research and innovations in basic science, drug discovery, translational medicine, and public health. ATCC is a 501(c)3 nonprofit organization with headquarters in Manassas, Virginia, and a research and technology center of excellence in Gaithersburg, Maryland. 

Contact: Kim Testa, senior director, Corporate Communications & Public Affairs, ATCC, [email protected]